Final report of University Hospital Hradec Kralove to the clinical trial protocol no.178-CL-101

Abstract

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder

Keywords

• Solifenacin Succinate
• Mirabegron
• Overactive Bladder